======= ZMYND8 ======= == Gene Information == * **Official Symbol**: ZMYND8 * **Official Name**: zinc finger MYND-type containing 8 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23613|23613]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9ULU4|Q9ULU4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ZMYND8&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZMYND8|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615713|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |Bromodomain| |PHD| |PWWP| |DUF3544| |regulation of postsynaptic density protein 95 clustering| |positive regulation of dendritic spine maintenance| |regulation of dendritic spine maintenance| |regulation of postsynaptic membrane organization| |regulation of postsynaptic density organization| |lysine-acetylated histone binding| |positive regulation of filopodium assembly| |dendritic shaft| |repressing transcription factor binding| |modulation of excitatory postsynaptic potential| |positive regulation of dendritic spine development| |regulation of filopodium assembly| |methylated histone binding| |positive regulation of dendrite development| |regulation of dendritic spine development| |regulation of postsynapse organization| |positive regulation of plasma membrane bounded cell projection assembly| |protein N-terminus binding| |regulation of nervous system process| |dendritic spine| |regulation of dendrite development| |regulation of protein localization to membrane| |regulation of plasma membrane bounded cell projection assembly| |regulation of cell projection assembly| |regulation of synapse organization| |regulation of synapse structure or activity| |transcription corepressor activity| |protein domain specific binding| |negative regulation of cell migration| |negative regulation of cell motility| |positive regulation of neuron projection development| |negative regulation of cellular component movement| |negative regulation of locomotion| |positive regulation of neuron differentiation| |positive regulation of cell projection organization| |regulation of membrane potential| |modulation of chemical synaptic transmission| |regulation of trans-synaptic signaling| |positive regulation of neurogenesis| |regulation of neuron projection development| |positive regulation of cellular component biogenesis| |positive regulation of nervous system development| |regulation of cellular protein localization| |positive regulation of cell development| |regulation of system process| |regulation of neuron differentiation| |regulation of plasma membrane bounded cell projection organization| |regulation of cell projection organization| |regulation of neurogenesis| |zinc ion binding| |regulation of cell migration| |regulation of cell motility| |regulation of cellular localization| |regulation of nervous system development| |regulation of cell development| |regulation of cellular component biogenesis| |positive regulation of cell differentiation| |regulation of locomotion| |regulation of cellular component movement| |regulation of protein localization| |positive regulation of cellular component organization| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |regulation of organelle organization| |negative regulation of RNA metabolic process| |positive regulation of developmental process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |generation of neurons| |negative regulation of biosynthetic process| |neurogenesis| |positive regulation of multicellular organismal process| |regulation of cell differentiation| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|1.7| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|1.72| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|1.83| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|1.9| |[[:results:exp34|Rotenone 20μM R00 exp34]]|1.91| |[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|1.92| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|1.92| |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|1.94| |[[:results:exp346|CoCl2 18μM R07 exp346]]|2.08| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|2.1| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|2.13| |[[:results:exp59|UMK57 1μM R01 exp59]]|2.21| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|2.32| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|2.8| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|2.96| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|2.96| ^Gene^Correlation^ |[[:human genes:z:znf592|ZNF592]]|0.475| |[[:human genes:b:brpf1|BRPF1]]|0.452| |[[:human genes:m:max|MAX]]|0.433| Global Fraction of Cell Lines Where Essential: 56/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|8/28| |bone|2/25| |breast|3/33| |central nervous system|5/56| |cervix|0/4| |colorectal|1/17| |esophagus|0/13| |fibroblast|0/1| |gastric|1/15| |kidney|0/21| |liver|0/20| |lung|3/75| |lymphocyte|2/14| |ovary|0/26| |pancreas|1/24| |peripheral nervous system|1/16| |plasma cell|9/15| |prostate|0/1| |skin|5/24| |soft tissue|1/7| |thyroid|1/2| |upper aerodigestive|0/22| |urinary tract|1/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1081 * **Expression level (log2 read counts)**: 6.51 {{:chemogenomics:nalm6 dist.png?nolink |}}